Why Thyrocare tests are so cheap?
Low-cost business model: Thyrocare works with a vast logistic network through its collection centres and home collection. Thus, they need not spend money on rental and infrastructure like shops. This reduces their operating expense. Thus they can offer tests at lower prices.
What does Thyrocare Tech do?
Thyrocare Technologies Limited was incorporated in the year January 28 2000. The company is one of the leading pan-India diagnostic chains that conduct an array of medical diagnostic tests and profiles of tests that center on early detection and management of disorders and diseases.
Is Thyrocare trusted?
So, the question that gets asked is – is thyrocare reliable? The answer is a big, resounding yes! – As a diagnostic lab that owns the next-level medical technology Thyrocare undoubtedly occupies a unique role in the market.
Who is the CEO of Thyrocare?
Arokiaswamy Velumani (1996–)Thyrocare / CEOArokiaswamy Velumani is an Indian scientist and entrepreneur. He is the founder, chairman and managing director of Thyrocare Technologies Ltd. a chain of diagnostic and preventive care laboratories headquartered in Navi Mumbai. Wikipedia
Which is better Lal Path or thyrocare?
In absolute terms, Thyrocare Technologies’ profit margin of 40% is far superior to Dr Lal PathLabs’ 26% margin in FY19, thanks to the former’s focus on the business to business (B2B) model, which helps it control costs.
Which is better Thyrocare or Lal Path Labs?
Who is Rahul Guha?
Rahul Guha, MD and CEO, Thyrocare Technologies Thyrocare Technologies, an API Group backed diagnostic laboratory services provider, has announced the appointment of Rahul Guha as its Managing Director and Chief Executive Officer with effect from 16th May 2022. Guha has joined API Group to head its Diagnostics Business.
When was thyrocare started?
1996Thyrocare / Founded
How big is Thyrocare?
As of November 2021, Thyrocare Technologies has an asset of 445.46cr (In Rupee).
Who bought Thyrocare?
PharmEasy’s parent API Holdings recently announced the acquisition of a majority stake in Thyrocare for Rs 4,546 crore.
When was Thyrocare started?
Why did PharmEasy buy Thyrocare?
At the time of announcing the deal, the company said that the collaboration between PharmEasy and Thyrocare would help accelerate the delivery of high-quality diagnostic and outpatient department (OPD) services across the full continuum of patient care to nearly 800 million Indians.
Is Thyrocare a good buy?
As on Jul 08,2022, THYROCARE TECHNOLOGIES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!
Who took over Thyrocare?
As part of the transaction, PharmEasy will acquire 66.1% stake in Thyrocare at a price of Rs 1,300 per share and will make an open offer to buy an additional 26% stake as per regulatory norms.
Has Thyrocare been sold?